Association of nucleoside diphosphate kinase nm23-H2 with human telomeres.

Telomeres, the ends of eukaryotic chromosomes, are essential structures formed by specific protein-DNA complexes that protect chromosomes from degradation and end-to-end fusion. TRF1, a double-stranded telomeric TTAGGG-repeat binding protein, is associated with mammalian telomeres and controls telomere length by inhibiting the action of telomerase. We identified human nucleoside diphosphate kinase nm23-H2 as a human TRF1-interacting protein by yeast two-hybrid screening. In vitro-binding assays using different recombinant nucleoside diphosphate kinases showed that TRF1 predominantly binds the nm23-H2 isoform rather than nm23-H1. Electrophoretic mobility shift analysis revealed that the recombinant nm23-H2 protein can bind the single-stranded telomeric TTAGGG-repeat while it cannot bind the double-stranded telomeric repeat. The synthetic 20 base oligoribonucleotide, which consists of the template sequence CUAACCCUAAC and the adjacent region of the RNA component of human telomerase, was also found to form the complex with the recombinant nm23-H2 protein. Furthermore, the affinity of telomerase for its substrate was increased in vitro by presence of the plentiful nm23-H2 protein. These findings indicate a close relationship between nm23-H2 and human telomeres and suggest a new biological role for nucleoside diphosphate kinase.

[1]  Bas van Steensel,et al.  Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.

[2]  M. L. Le Beau,et al.  Comparison of the human and mouse genes encoding the telomeric protein, TRF1: chromosomal localization, expression and conserved protein domains. , 1997, Human molecular genetics.

[3]  F. Ishikawa,et al.  A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. , 1996, Oncogene.

[4]  B. van Steensel,et al.  Structure, subnuclear distribution, and nuclear matrix association of the mammalian telomeric complex , 1996, The Journal of cell biology.

[5]  M. Véron,et al.  Nuclear localization of nucleoside diphosphate kinase type B (nm23-H2) in cultured cells. , 1996, Experimental cell research.

[6]  C. Greider,et al.  Telomere length regulation. , 1996, Annual review of biochemistry.

[7]  H. Erdjument-Bromage,et al.  A Human Telomeric Protein , 1995, Science.

[8]  M. Lacombe,et al.  A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences. , 1995, Nucleic acids research.

[9]  P. Wagner,et al.  Phosphorylation of ATP-Citrate Lyase by Nucleoside Diphosphate Kinase (*) , 1995, The Journal of Biological Chemistry.

[10]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[11]  Roger L. Williams,et al.  Nm23/nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functions , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  E. Liu,et al.  Oncogenes and Tumor Suppressor Genes in Human Malignancies , 2012, Cancer Treatment and Research.

[13]  P. Steeg,et al.  A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. , 1993, The Journal of biological chemistry.

[14]  S. J. Flint,et al.  Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. , 1993, Science.

[15]  Z. Zhong,et al.  A mammalian factor that binds telomeric TTAGGG repeats in vitro , 1992, Molecular and cellular biology.

[16]  A. Chaffotte,et al.  A Pro/Ser substitution in nucleoside diphosphate kinase of Drosophila melanogaster (mutation killer of prune) affects stability but not catalytic efficiency of the enzyme. , 1992, The Journal of biological chemistry.

[17]  H. Magdelenat,et al.  Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph‐node metastasis , 1992, International journal of cancer.

[18]  A. Gilles,et al.  Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. , 1991, The Journal of biological chemistry.

[19]  Michael R. Green,et al.  Mechanism of action of an acidic transcriptional activator in vitro , 1991, Cell.

[20]  N. Tsuyama,et al.  SV40 T-antigen is required for maintenance of immortal growth in SV40-transformed human fibroblasts. , 1991, Cell structure and function.

[21]  P. Steeg,et al.  H 2 Gene , nm 23 Identification of a Second Human Updated , 2006 .

[22]  D. Kipling,et al.  Hypervariable ultra-long telomeres in mice , 1990, Nature.

[23]  Fred Winston,et al.  Methods in Yeast Genetics: A Laboratory Course Manual , 1990 .

[24]  M. Ptashne,et al.  Activators and targets , 1990, Nature.

[25]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[26]  L. Liotta,et al.  Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development , 1989, Nature.

[27]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.

[28]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .